MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
CVS CVS Health
- 44.360
- +0.580+1.32%
Close Dec 20 16:00 ET
- 44.400
- +0.040+0.09%
Post 20:01 ET
55.82BMarket Cap11.26P/E (TTM)
44.768High43.680Low21.45MVolume43.720Open43.780Pre Close950.20MTurnover1.71%Turnover Ratio6.86P/E (Static)1.26BShares79.90452wk High0.74P/B55.70BFloat Cap43.60052wk Low2.60Dividend TTM1.26BShs Float101.691Historical High5.86%Div YieldTTM2.48%Amplitude6.354Historical Low44.303Avg Price1Lot Size
CVS Health Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -127.43%-745M | -47.71%3.09B | -34.08%4.9B | -17.01%13.43B | -35.04%-2.64B | -70.23%2.72B | 8.54%5.91B | 108.76%7.44B | -11.43%16.18B | -148.74%-1.95B |
| Net income from continuing operations | -96.87%71M | -7.63%1.77B | -47.53%1.12B | 93.39%8.37B | -12.22%2.05B | 166.64%2.27B | -37.02%1.91B | -9.04%2.14B | -45.84%4.33B | 68.13%2.33B |
| Operating gains losses | ---- | ---- | ---- | -83.04%349M | ---- | ---- | ---- | ---- | 355.31%2.06B | -367.42%-238M |
| Depreciation and amortization | 3.02%1.16B | 4.26%1.15B | 13.69%1.14B | 3.36%4.37B | 8.72%1.13B | 7.33%1.13B | 2.03%1.1B | -4.58%1B | -5.84%4.22B | -4.22%1.04B |
| Deferred tax | -128.40%-571M | -82.35%-124M | -240.00%-217M | 66.68%-676M | -378.80%-513M | 87.29%-250M | 4.23%-68M | 188.57%155M | -404.73%-2.03B | -24.28%184M |
| Other non cash items | ---- | ---- | ---- | 25.30%416M | ---- | ---- | ---- | ---- | 185.13%332M | ---- |
| Change In working capital | -225.00%-2.38B | -94.15%161M | -32.60%2.72B | -99.78%15M | -5.83%-6.04B | -106.77%-732M | 87.22%2.75B | 1,547.76%4.04B | 76.77%6.82B | -6,375.82%-5.71B |
| -Change in receivables | -21.44%-3.78B | -296.23%-210M | 500.53%3.01B | -110.70%-6.26B | -143.24%-2.34B | -559.59%-3.12B | 92.64%-53M | 61.82%-751M | -9.91%-2.97B | -220.10%-962M |
| -Change in inventory | -219.60%-1.58B | -71.50%277M | 100.48%1.66B | 185.92%1.23B | 92.94%-72M | 44.00%-495M | 11.85%972M | 307.00%828M | -295.24%-1.44B | -181.77%-1.02B |
| -Change in payables and accrued expense | -22.33%2.28B | 86.02%1.93B | -73.48%843M | -23.61%4.01B | -21.72%-3.13B | -35.01%2.93B | 1,320.00%1.04B | -6.61%3.18B | 75.13%5.25B | -94.70%-2.57B |
| -Change in other current assets | 252.15%1.39B | 73.98%595M | -125.98%-2.84B | -3.87%-510M | 103.24%8M | 840.48%395M | 451.61%342M | -260.63%-1.26B | -1,536.67%-491M | -525.86%-247M |
| -Change in other current liabilities | -52.58%-679M | -632.89%-2.43B | -97.74%46M | -76.17%1.54B | 44.16%-507M | -106.88%-445M | -66.10%456M | 558.56%2.04B | 126.30%6.46B | -199.13%-908M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -127.43%-745M | -47.71%3.09B | -34.08%4.9B | -17.01%13.43B | -35.04%-2.64B | -70.23%2.72B | 8.54%5.91B | 108.76%7.44B | -11.43%16.18B | -148.74%-1.95B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -334.11%-3.35B | 84.32%-1.63B | 75.41%-2.09B | -313.89%-20.89B | -943.70%-1.24B | 4.22%-771M | -386.48%-10.36B | -327.20%-8.51B | 4.07%-5.05B | 91.74%-119M |
| Net PPE purchase and sale | -22.94%-670M | -7.95%-638M | 28.35%-705M | -11.15%-3.03B | -32.41%-911M | 6.03%-545M | -44.85%-591M | 6.37%-984M | -8.21%-2.73B | -15.24%-688M |
| Net business purchase and sale | 33.33%-12M | 99.49%-48M | 99.65%-25M | -1,096.83%-16.61B | -117.88%-120M | -300.00%-18M | -355.12%-9.38B | -101,242.86%-7.09B | -850.68%-1.39B | 6,200.00%671M |
| Net investment purchase and sale | -1,123.74%-2.68B | -147.70%-971M | -198.07%-1.39B | -29.20%-1.31B | -108.85%-236M | 13.78%-219M | -254.33%-392M | 48.34%-467M | 62.57%-1.02B | 86.85%-113M |
| Net other investing changes | 36.36%15M | 3,100.00%32M | -9.68%28M | -20.00%68M | 127.27%25M | -45.00%11M | -98.82%1M | 200.00%31M | -30.33%85M | -59.26%11M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -334.11%-3.35B | 84.32%-1.63B | 75.41%-2.09B | -313.89%-20.89B | -943.70%-1.24B | 4.22%-771M | -386.48%-10.36B | -327.20%-8.51B | 4.07%-5.05B | 91.74%-119M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 41.12%-1.59B | -65.55%1.25B | -145.01%-1.23B | 125.51%2.68B | 55.56%-972M | 16.19%-2.7B | 247.34%3.63B | 202.87%2.73B | 7.40%-10.52B | 24.95%-2.19B |
| Net issuance payments of debt | 55.37%-869M | -50.88%2.22B | -55.25%2.5B | 288.36%7.93B | -1,350.00%-232M | 26.97%-1.95B | 398.48%4.52B | 40,021.43%5.59B | 54.56%-4.21B | 99.34%-16M |
| Net common stock issuance | -66.67%1M | 50.00%3M | -50.00%-3.03B | 42.51%-2.01B | 100.07%1M | --3M | --2M | -0.90%-2.02B | ---3.5B | ---1.5B |
| Cash dividends paid | -7.45%-837M | -7.92%-858M | -7.83%-840M | -7.74%-3.13B | -8.34%-779M | -7.30%-779M | -7.43%-795M | -7.89%-779M | -10.74%-2.91B | -8.94%-719M |
| Proceeds from stock option exercised by employees | -6.56%114M | 4.17%25M | 111.46%203M | -49.73%277M | -14.63%35M | -24.69%122M | -52.94%24M | -67.68%96M | 0.36%551M | -62.39%41M |
| Net other financing activities | 103.13%3M | -11.81%-142M | 60.49%-64M | 14.92%-382M | -57.14%3M | -900.00%-96M | 50.58%-127M | 23.22%-162M | -3,353.85%-449M | -89.71%7M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 41.12%-1.59B | -65.55%1.25B | -145.01%-1.23B | 125.51%2.68B | 55.56%-972M | 16.19%-2.7B | 247.34%3.63B | 202.87%2.73B | 7.40%-10.52B | 24.95%-2.19B |
| Net cash flow | ||||||||||
| Beginning cash position | -9.25%12.82B | -32.42%10.11B | -35.93%8.53B | 4.84%13.31B | -23.85%13.38B | 13.35%14.13B | 28.80%14.96B | 4.84%13.31B | 14.92%12.69B | 34.69%17.56B |
| Current changes in cash | -655.32%-5.68B | 427.66%2.71B | -4.12%1.58B | -878.50%-4.78B | -13.90%-4.85B | -114.75%-752M | -197.18%-828M | 252.78%1.65B | -62.74%614M | -1,120.06%-4.26B |
| End cash Position | -46.62%7.14B | -9.25%12.82B | -32.42%10.11B | -35.93%8.53B | -35.93%8.53B | -23.85%13.38B | 13.35%14.13B | 28.80%14.96B | 4.84%13.31B | 4.84%13.31B |
| Free cash flow | -165.18%-1.42B | -53.90%2.45B | -34.96%4.2B | -22.71%10.4B | -34.36%-3.55B | -74.59%2.17B | 5.60%5.32B | 156.93%6.45B | -14.58%13.45B | -177.46%-2.64B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
